About
Lynkpharma is a clinical-stage biopharmaceutical company focused on developing innovative and differentiated small-molecule therapies for autoimmune and inflammatory diseases, leveraging AI-assisted drug design and protein degradation technologies.
Explore Lynkpharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.